Geneva, Switzerland, May 8, 2024 – Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug…
SINGAPORE, May 8, 2024 /PRNewswire/ — MetaComp Pte Ltd and its subsidiaries (collectively referred to as “MetaComp”) and Bosera Fund Management (International)…